Accueil Catalogue Qualité & COA À propos Contact Panier
Parcourir le catalogue
Livraison gratuite pour les commandes de plus de $59 · $7.99 États-Unis (48h) · $14.99 mondial (5 jours) · Emballage discret · Crypto accepté
Lyophilisé · 5 mg + 5 mg / vial CJC-1295 No DAC + Ipamorelin Blend 5 mg + 5 mg / vial — Flacon de peptide vérifié par HPLC
Growth & Anabolic 5 mg + 5 mg / vial

CJC-1295 + Ipamorelin Blend (5mg + 5mg)

GHRH + selective GHRP synergistic stack · Co-lyophilized · Single vial, one injection

Premium Grade Meilleures ventes

Co-lyophilized GHRH + selective GHRP stack — the reference combination for synergistic pulsatile GH release.

Numéro CAS
Blend
Poids moléculaire
Mixed (3 368 + 712 Da)
Pureté
≥ 99.0% (HPLC, each component)
Stockage
−20 °C, lyophilisé
Séquence d'acides aminés CJC-1295 (Mod GRF 1-29) co-lyophilized with Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2)
Choisissez votre lot
Vous payez aujourd'hui $102 3 flacons · $34/flacon
Gratuit pour les commandes de plus de $59$7.99 vers les États-Unis (48h) · $14.99 dans le monde (5 jours ouvrés)
Emballage discretEnveloppe isotherme discrète, aucun nom de composé à l'extérieur.

Certificat d'analyse

Rapport analytique par lot — HPLC, ESI-MS, endotoxine LAL, métaux lourds, stérilité

Lot actuelCJC772
Libéré2026-04-17
Pureté HPLC99.77%
Endotoxine (LAL)Réussi · < 0,5 EU/mg

À propos de CJC-1295 No DAC + Ipamorelin Blend

Buy the CJC-1295 + Ipamorelin blend at IGF1 Shop. This pre-blended vial contains 5mg of CJC-1295 (No DAC, also called Modified GRF 1-29) co-lyophilized with 5mg of Ipamorelin in a single vial — the reference GHRH + GHRP combination for synergistic pulsatile growth hormone release. CJC-1295 No DAC primes the pituitary via the GHRH receptor; Ipamorelin selectively triggers the release via the ghrelin receptor (GHS-R1a). The two combined produce a GH pulse two to five times larger than either alone, without raising cortisol or prolactin. Each blend lot is HPLC ≥99% for each component, mass-spec verified, with a per-lot COA.

Également connu sous le nom de : CJC-1295 Ipamorelin · CJC + Ipamorelin blend · GHRH/GHRP stack · Mod GRF + Ipamorelin

CJC-1295 No DAC + Ipamorelin Blend — Mécanisme & Spécifications

This blend co-lyophilizes the foundational GHRH analog (Mod GRF 1-29) with the selective ghrelin-receptor agonist Ipamorelin in a single vial. The two compounds activate distinct receptors on somatotrophs and produce a synergistic GH pulse far greater than either compound alone, without elevating cortisol or prolactin.

Qualité & critères de libération

Chaque lot de CJC-1295 No DAC + Ipamorelin Blend n'est libéré qu'après avoir réussi l'HPLC en phase inverse (≥ 99% de pureté aire à 220 nm par rapport à un standard de référence), la confirmation spectrométrie de masse ESI du poids moléculaire, et le test d'endotoxines LAL (Limulus Amebocyte Lysate) en dessous de 0,5 EU/mg. Le Certificat d'analyse spécifique au lot est fourni avec la commande et disponible sur demande avant achat.

FAQ

CJC-1295 No DAC + Ipamorelin Blend — Questions fréquentes

Why blend CJC-1295 (No DAC) with Ipamorelin?
CJC-1295 No DAC is a GHRH analog — it primes the pituitary to release GH. Ipamorelin is a selective GHRP — it triggers the actual release through the ghrelin receptor pathway. Combined, the two produce a GH pulse that is synergistic, two to five times larger than either compound alone, without raising cortisol or prolactin.
What is the standard blend protocol?
The most common protocol is 100 mcg of each peptide together, one to three times per day, subcutaneously. Many users dose once first thing in the morning (fasted) and once 30 minutes before bed. With a 5mg + 5mg blend vial reconstituted in 2mL bacteriostatic water, 0.04mL (4 units on a U-100) delivers 100mcg of each.
How long until effects are noticeable?
Sleep quality typically improves within the first week of the CJC-1295 + Ipamorelin blend. Recovery, skin quality, and body-composition changes generally appear after 4-8 weeks of consistent dosing. Most users run blocks of 8-12 weeks followed by a 4-week break to prevent receptor desensitization.
How should the vial be reconstituted and stored?
Add 2mL of bacteriostatic water down the side of the vial, swirl until clear, do not shake. Keep refrigerated at 2-8 °C and use within 30 days of reconstitution. Pre-reconstitution shelf life of the lyophilized blend is two years at -20 °C.
What purity testing does the blend carry?
Each peptide in the CJC-1295 + Ipamorelin blend is independently HPLC ≥99%, then co-lyophilized in a 1:1 mass ratio in the same vial. Identity is confirmed by ESI mass-spec, endotoxin by LAL <0.5 EU/mg, sterility per USP <71>. The COA is issued by an ISO 17025 laboratory and tied to your lot.
Can I run the blend with other peptides like BPC-157 or TB-500?
Yes — the CJC-1295 + Ipamorelin blend is commonly stacked with healing peptides like BPC-157 or TB-500, taken in separate syringes at different times of day. Avoid stacking with other GHRP/GHRH peptides simultaneously, as it provides no added benefit and accelerates receptor desensitization.